Skip to main content
Signal8

COLLEGIUM PHARMACEUTICAL, INC (COLL)

Sector: Pharmaceutical Preparations

Industry: Drug Manufacturers - Specialty & Generic

Collegium Pharmaceutical, Inc. logo

Collegium Pharmaceutical, Inc.

NASDAQ:COLLHealthcare
Pre+0.33%$24.29
Close$24.21-3.78%AH$24.29+0.33%vs close
Mkt Cap$752.34M
Float30.6M
O/S31.08M
PM VOL5K sh
$ Vol≈$125K
RVOL9.11×
Inst Own-
SI17.6%
Dilution
Collegium Pharmaceutical, Inc. logoNASDAQ:COLLPre$24.29+0.33%
Historical Data
DateOpenHighLowCloseVolume
Nov 6, 202624.0624.8023.7124.21775,576
Nov 5, 202625.7426.3924.3225.161,573,887
Nov 4, 202624.1124.4823.4123.67803,991
Nov 3, 202623.6723.9223.4923.73524,868
Nov 2, 202623.9624.0823.2523.68600,669
Oct 30, 202624.2824.5023.6623.80401,933
Oct 29, 202623.7024.1823.5724.03656,455
Oct 28, 202622.7823.3122.6623.23406,094
Oct 27, 202623.0823.2922.7423.00486,611
Oct 26, 202622.9623.5222.9223.21518,254
Oct 23, 202623.3023.4922.1522.96662,374
Oct 22, 202623.0323.8422.9423.50738,765
Oct 21, 202623.1323.1522.5722.91480,417
Oct 20, 202623.5423.8422.8923.23536,155
Oct 19, 202622.9923.5422.7423.01713,872
Oct 16, 202623.4023.4122.8623.19558,736
Oct 15, 202623.0624.0423.0623.181,001,997
Oct 14, 202621.6522.5621.4722.51920,242
Oct 13, 202622.0522.2121.4621.53846,422
Oct 12, 202622.1422.2821.7922.05528,695
Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target (median, last 90d)
$48.50+100.3%
Low $45High $50
Ratings Distribution
BUY
8
HOLD
3
SELL
1
TOTAL12
Insider Trades
InsiderTypeShares
SANTINI GINO profile photoSANTINI GINOOption Exercise8.7K
SANTINI GINO profile photoSANTINI GINOOption Exercise8.7K
Freund John Gordon profile photoFreund John GordonSale20
Freund John Gordon profile photoFreund John GordonOption Exercise8.7K
Freund John Gordon profile photoFreund John GordonSale4.1K
Freund John Gordon profile photoFreund John GordonOption Exercise8.7K
Shareholders
-
Institutionalⓘ
(267)
3.9%
Insiderⓘ
(15)
0.8%
5%+ Owners
(1)
-
Unattributed (incl. retail)ⓘ
Insider3.9%
5%+ Beneficial0.8%
Top Shareholders
NameShares%
BlackRock, Inc. logo
BlackRock, Inc.
5.4M17.5%
BlackRock, Inc. logo
BlackRock, Inc.
· also on 13F· may incl. warrants· filed Apr 2025
5.0M16.1%
Millennium Group Management LLC logo
Millennium Group Management LLC
· also on 13F· joint filing· may incl. warrants· filed Oct 2026
2.4M7.7%
Jupiter Topco LLC logo
Jupiter Topco LLC
2.1M6.9%
Invesco Ltd. logo
Invesco Ltd.
1.9M6.1%
FULLER & THALER ASSET MANAGEMENT, INC. logo
FULLER & THALER ASSET MANAGEMENT, INC.
1.6M5.3%
Vanguard Capital Management logo
Vanguard Capital Management
· net of 13F· may incl. warrants· filed Oct 2026
1.6M5.2%
Invesco Ltd. logo
Invesco Ltd.
· also on 13F· may incl. warrants· filed Aug 2025
1.6M5.1%
STATE STREET CORP logo
STATE STREET CORP
1.5M4.9%
PRINCIPAL FINANCIAL GROUP INC logo
PRINCIPAL FINANCIAL GROUP INC
1.5M4.9%
Sources: 13F, Form 4, 13D/13GO/S: 31.1M · as of 31 Oct 2026 · SEC cover page
Insiders & Institutional Holders

Insiders

Top institutional holders

About

Collegium Pharmaceutical, Inc. (COLL) is a specialized pharmaceutical firm dedicated to the development and marketing of medications for pain management.

Its diverse product lineup features significant therapies aimed at addressing various pain conditions. A prominent offering is Xtampza ER, an extended-release, oral formulation of oxycodone, specifically engineered with properties to deter abuse. This particular drug is prescribed for patients experiencing severe, persistent pain that necessitates daily, continuous, long-term opioid therapy.

The company's portfolio also encompasses Nucynta ER and Nucynta IR, which are extended-release and immediate-release versions of tapentadol, respectively. Founded in 2002, the enterprise initially operated under the name Collegium Pharmaceuticals, Inc., before officially adopting its current identity as Collegium Pharmaceutical, Inc. in October 2003.

The company's corporate headquarters are situated in Stoughton, Massachusetts.

Key Metrics
Market Cap$752.34M
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership-

13F filers report 38.77M shares, more than the 31.08M outstanding, so no percentage is shown. 13F reports lag by a quarter and shares lent to short sellers can be counted twice.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ExchangeNASDAQ
CountryUSUS
IPO DateMay 7, 2015
Shares Outstanding31.08M
Authorized Shares
Float30.60M
52-Week Range
$21.43$50.79
$24.21(9th percentile)
Volume
Average Daily Volume686.80K
775.58K today vs 686.80K avg(+13%)

30d Avg

686.80K

60d Avg

765.36K

90d Avg

810.14K

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...